Clin2
NCT07226596Likely a fitRecruiting

Methamphetamine use: can you reduce without quitting?

Methamphetamine Use Disorder

Part of Mental health clinical trials.

This study tests whether people who use methamphetamine can reduce use even if they are not completely abstinent. It offers a 12-week program and checks how you're doing for another 12 weeks after.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 or older.
  • You have used methamphetamine in the past week and have a positive urine test.
  • You meet criteria for moderate to severe methamphetamine use disorder.
  • You want treatment for your meth use and can stay in the study for 12 weeks plus a 12-week follow-up.
  • If you take buprenorphine or methadone for opioid use disorder, you can still join.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06989853Recruiting· Early Phase 1
Testing troriluzole for methamphetamine use disorder

This study tests whether a medication called troriluzole can help people who use methamphetamine. If you have methamphetamine use disorder and are not seeking treatment right now, this study may be an option for you.

Lexington, Kentucky
NCT07086014Recruiting
Brain response to methamphetamine cues in men

This study uses brain scans to see how men with methamphetamine use disorder react to images or reminders of the drug. It aims to understand cravings and brain activity, which could help improve treatments.

New York, New York
NCT07211724Not yet recruiting
Heart failure support for people with methamphetamine use

This study tests a support program for people with heart failure who also use methamphetamine and want to quit. It aims to improve both heart health and recovery from substance use.

Los Angeles, California
NCT06899594Recruiting· Early Phase 1
Psilocybin for quitting methamphetamine

This trial tests whether psilocybin (a psychedelic medicine) can help people quit methamphetamine. You'll receive counseling before, during, and after the drug session, and your progress will be followed for several months.

Shreveport, Louisiana
NCT06931197Not yet recruiting
Start treatment for methamphetamine use after a traumatic injury

This study tests whether starting a reward-based treatment program while you are still in the hospital can help reduce methamphetamine use after a traumatic injury. You may be able to join if you test positive for methamphetamine, use it at least weekly, and have moderate or severe trouble controlling your use.

Honolulu, Hawaii
NCT07774702Not yet recruiting· Phase 2
Psilocybin for methamphetamine use disorder

This trial tests whether a psychedelic drug called psilocybin can help people cut down or stop using methamphetamine. You'll take the drug in a supervised setting and get support to aim for full abstinence.

Birmingham, Alabama

Hear when a new Methamphetamine Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.